The Hampstead Theatre is hosting a new play, ROI, written by US businessman-turned-playwright Aaron Loeb. The drama explores the intersection of medical technology and venture capitalism, centering on a research scientist, Willa (Letty Thomas), who pitches a groundbreaking method for predicting cancer to a sleek San Francisco venture capital firm.
Willa is initially dismissed by ambitious associate May (Millicent Wong) until the discovery is recognised as a high-value 'unicorn' startup. The company boss, Paul (Lloyd Owen), sees profit potential, but the marriage of cutting-edge science and business leads to ethical dilemmas. Loeb's own business background shines through in the quick-fire dialogue, reminiscent of David Mamet's Glengarry Glen Ross.
Directed by Chelsea Walker, the play unfolds in Paul's Silicon Valley-style office, designed by Rosie Elnile. The set reconfigures rapidly as scenes jump from the Covid era to a near future. Scientific breakthroughs include cures for cancer and Alzheimer's, as well as 'precures', and the potential for designer babies is raised. The plot also touches on political fallout, with a US congressional committee involved, and includes personal subplots such as an extramarital affair and a character with early onset dementia.
The play attempts to cover many ideas within its 100-minute runtime, but the personal stories are too brief to evoke strong emotion. Performances are strong, yet characters remain sketchy and sometimes clichéd, like Paul with his yoga mat and smoothies. Paul starts as an idealist who wants to save the world but quickly prioritises profit. Willa, the scientist, espouses problematic views on race and genetics, drawing her towards right-wing forces. The play ultimately serves as a reminder that pure scientific discovery cannot remain pure.
